Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observational Study of Avastin (Bevacizumab) in Combination With Chemotherapy for Treatment of Metastatic or Locally Advanced and Unresectable Colorectal Adenocarcinoma

NCT00097578 is registered in ClinicalTrials.gov with Genentech, Inc. as lead sponsor.

NCT NCT00097578
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00097578 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observational Study of Avastin (Bevacizumab) in Combination With Chemotherapy for Treatment of Metastatic or Locally Advanced and Unresectable Colorectal Adenocarcinoma
Lead sponsor
Genentech, Inc.
Phase
Observational
Overall status
Completed
Start date
March 31, 2004
Completion date
July 31, 2008
Enrollment
1,953 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer